Rent

Warner Bros. Discovery’s Max recently announced price increases for its ad-free options, raising concerns among subscribers of the popular streaming service. The news comes at a time when several other streaming platforms are also hiking their membership fees, making it more expensive for consumers to access their favorite content online. Max currently offers three pricing
0 Comments
Paramount and Skydance have reached an agreement on the terms of a merger, as reported by CNBC’s David Faber. The deal, which could be announced in the coming days, involves a consortium led by David Ellison’s Skydance, with backing from private equity firms RedBird Capital and KKR. The terms have been agreed upon by a
0 Comments
Moderna and Merck, two leading pharmaceutical companies, have recently released promising three-year data on their experimental vaccine in combination with Keytruda therapy for patients with a deadly form of skin cancer. The released data shows significant improvement in survival rates and long-lasting efficacy in a midstage study presented at the American Society of Clinical Oncology
0 Comments
The emergence of Financial TikTok, or #FinTok, has drawn the attention of many individuals, particularly those belonging to Generation Z. This group has shown an increasing interest in obtaining financial information, tips, and advice through various social media platforms like TikTok, YouTube, and Instagram. This shift can be attributed to the limited access this generation
0 Comments
Kelly Harry discovered she was underpaid early in her career when she realized her colleague was making significantly more money than her. This realization led to Harry researching the market and the value of her skills to determine the discrepancy in pay. The issue of underpayment is not uncommon in the workplace, with a significant
0 Comments
Pfizer recently unveiled exciting news regarding its drug, Lorbrena, in the treatment of advanced lung cancer. The results of a late-stage trial showed promising long-term outcomes, positioning Lorbrena as a potential new standard in addressing this condition. The drug demonstrated the ability to extend patients’ lives without cancer progression for over five years, along with
0 Comments